+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Platform Market by Product Type, Therapeutic Area, End User - Global Forecast to 2030- Product Image
mRNA Platform Market by Product Type, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

mRNA Platform Market by Product Type, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460245
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA platform market is advancing at a remarkable pace, propelled by innovation in therapeutic and diagnostic applications. Senior leaders today require a clear, strategic view to assess trends, mitigate risk, and steer investments effectively in the evolving mRNA landscape.

Market Snapshot: mRNA Platform Market Growth Trajectory

The mRNA platform market grew from USD 16.33 billion in 2024 to USD 19.93 billion in 2025. It is expected to continue growing at a CAGR of 21.60%, reaching USD 52.83 billion by 2030. Adoption is driven by advances in mRNA technology, increased demand for next-generation vaccines, and a shift towards targeted therapies. The market is shaped by collaborative partnerships and maturing regulatory environments, underscoring the importance of supply chain agility and integration for stakeholders across biopharma, diagnostics, and academia.

Scope & Segmentation: Detailed Market Coverage

  • Product Types: Diagnostics for cancer and infectious diseases, drug discovery reagents including screening and transfection agents, research kits for lipid nanoparticle assembly and mRNA synthesis, therapeutics spanning cardiology, neurology, oncology, rare diseases, and vaccines in both prophylactic and therapeutic forms.
  • Therapeutic Areas: Cardiology (arrhythmias, heart failure), infectious diseases (COVID-19, influenza, rabies), neurologic conditions (Alzheimer’s, Parkinson’s), oncology (hematologic malignancies, solid tumors), and rare diseases (genetic, metabolic disorders).
  • End Users: Academic centers such as colleges and universities, diagnostic labs including hospital and reference facilities, hospitals (public and private), pharmaceutical companies (large and small), and research institutes (government and private).
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Saudi Arabia, South Africa), and Asia-Pacific (including China, India, Japan, Australia, Singapore, and others).
  • Leading Companies: Key players profiled include Moderna, BioNTech, CureVac, Arcturus, Pfizer, Sanofi, GlaxoSmithKline, Vaxart, Gritstone, and Providence Therapeutics.

Key Takeaways: Strategic Industry Insights

  • mRNA technologies are being rapidly translated from laboratory research into clinical and commercial pipelines, supported by better delivery systems and nucleotide modifications.
  • Strategic alliances between pharmaceutical firms, academic groups, and CROs accelerate innovation and bring new therapeutic candidates to market.
  • Investors and developers are increasingly relying on platform-based models to diversify risk across multiple therapeutic indications.
  • End users are adopting specialized diagnostic kits and research modules, enhancing operational flexibility and precision targeting.
  • Geographic differences necessitate region-specific entry strategies, with mature markets focusing on innovation and emerging regions prioritizing capacity and technology transfer.

Tariff Impact: Navigating U.S. Policy Shifts

The 2025 introduction of updated U.S. tariffs has created immediate challenges for mRNA supply chains by increasing duties on specialized reagents and raw materials. Organizations are responding by diversifying supplier bases and investing in domestic production, though these measures require significant time and resource commitment. The industry is prioritizing renegotiation of procurement contracts and building resilient supply networks to address ongoing cost pressures and maintain innovation speed.

Methodology & Data Sources

This report draws on primary research—structured interviews with subject matter experts in formulation, clinical development, and regulatory strategy—supplemented by in-depth reviews of scientific publications and market filings. Quantitative findings are validated against supply chain datasets and financial records, ensuring robust analysis of the mRNA platform market and its evolving landscape.

Why This Report Matters

  • Offers actionable guidance for decision-makers seeking to optimize investments and navigate changing regulations in the mRNA platform market.
  • Delivers segment-level insights to identify opportunities for product and service innovation aligned to genuine end-user needs.
  • Enables strategic planning by contextualizing geographic trends, partnership models, and adaptive manufacturing approaches.

Conclusion

The ongoing transformation of the mRNA platform market requires a comprehensive, data-driven perspective. This report equips senior leaders with the critical intelligence needed to refine market strategies, foster meaningful collaborations, and achieve lasting growth in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Platform Market, by Product Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Cancer
8.2.2. Infectious
8.3. Drug Discovery Reagents
8.3.1. Screening Reagents
8.3.2. Transfection Reagents
8.4. Research Kits
8.4.1. Lipid Nanoparticles
8.4.2. MRna Synthesis Kits
8.5. Therapeutics
8.5.1. Cardiology
8.5.2. Neurologic
8.5.3. Oncology
8.5.4. Rare Diseases
8.6. Vaccines
8.6.1. Prophylactic
8.6.2. Therapeutic
9. mRNA Platform Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiology
9.2.1. Arrhythmia
9.2.2. Heart Failure
9.3. Infectious
9.3.1. COVID-19
9.3.2. Influenza
9.3.3. Rabies
9.4. Neurologic
9.4.1. Alzheimer’s
9.4.2. Parkinson’s
9.5. Oncology
9.5.1. Hematologic Malignancies
9.5.2. Solid Tumors
9.6. Rare Diseases
9.6.1. Genetic Disorders
9.6.2. Metabolic Disorders
10. mRNA Platform Market, by End User
10.1. Introduction
10.2. Academic Centers
10.2.1. Colleges
10.2.2. Universities
10.3. Diagnostic Labs
10.3.1. Hospital Labs
10.3.2. Reference Labs
10.4. Hospitals
10.4.1. Private
10.4.2. Public
10.5. Pharmaceutical Companies
10.5.1. Large
10.5.2. Small
10.6. Research Institutes
10.6.1. Government
10.6.2. Private
11. Americas mRNA Platform Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa mRNA Platform Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific mRNA Platform Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Moderna, Inc.
14.3.2. BioNTech SE
14.3.3. CureVac SE
14.3.4. Arcturus Therapeutics Holdings, Inc.
14.3.5. Pfizer Inc.
14.3.6. Sanofi S.A.
14.3.7. GlaxoSmithKline plc
14.3.8. Vaxart, Inc.
14.3.9. Gritstone bio, Inc.
14.3.10. Providence Therapeutics Holdings Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MRNA PLATFORM MARKET MULTI-CURRENCY
FIGURE 2. MRNA PLATFORM MARKET MULTI-LANGUAGE
FIGURE 3. MRNA PLATFORM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MRNA PLATFORM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. CANADA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. CANADA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 114. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 115. CANADA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 116. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 117. CANADA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 118. CANADA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 119. CANADA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 120. CANADA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 121. CANADA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 122. CANADA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. CANADA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 124. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 125. CANADA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. CANADA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 127. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 135. MEXICO MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 138. MEXICO MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. MEXICO MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. MEXICO MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 145. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. GERMANY MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 224. GERMANY MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 225. GERMANY MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 226. GERMANY MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 227. GERMANY MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 228. GERMANY MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 229. GERMANY MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 230. GERMANY MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. GERMANY MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 234. GERMANY MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 236. GERMANY MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 237. FRANCE MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. FRANCE MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 243. FRANCE MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 244. FRANCE MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 245. FRANCE MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 246. FRANCE MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 247. FRANCE MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 248. FRANCE MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 249. FRANCE MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. FRANCE MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 252. FRANCE MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 254. FRANCE MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 273. ITALY MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. ITALY MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. ITALY MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 276. ITALY MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 277. ITALY MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 278. ITALY MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 279. ITALY MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 280. ITALY MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 281. ITALY MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 282. ITALY MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 283. ITALY MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 284. ITALY MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 285. ITALY MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. ITALY MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 287. ITALY MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 288. ITALY MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. ITALY MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. ITALY MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. SPAIN MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 295. SPAIN MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 296. SPAIN MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 297. SPAIN MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 298. SPAIN MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 299. SPAIN MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 300. SPAIN MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 301. SPAIN MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 302. SPAIN MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 303. SPAIN MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SPAIN MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 306. SPAIN MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. SPAIN MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 308. SPAIN MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 336. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 338. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 344. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2030 (USD MILLION)
TABLE 348. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 350. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 352. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 354. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Platform market report include:
  • Moderna, Inc.
  • BioNTech SE
  • CureVac SE
  • Arcturus Therapeutics Holdings, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Vaxart, Inc.
  • Gritstone bio, Inc.
  • Providence Therapeutics Holdings Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 19.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 52.83 Billion
Compound Annual Growth Rate21.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast to 2030 - Product Image

mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
mRNA Platform - Global Strategic Business Report - Product Image

mRNA Platform - Global Strategic Business Report

  • Report
  • 334 Pages
  • Global
From
Porcine Vaccines Market by Vaccine Type, Disease Indication, End User, Route of Administration, Technology, Dosage Form - Global Forecast to 2030 - Product Image

Porcine Vaccines Market by Vaccine Type, Disease Indication, End User, Route of Administration, Technology, Dosage Form - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions - Product Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

  • Report
  • 343 Pages
  • Global
From
mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 159 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.